AgomAb Therapeutics N.V. American Depositary Shares Current Cash

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) currently reports a current cash of $220M as of June 2026. Use the charts on this page to explore AgomAb Therapeutics N.V. American Depositary Shares's current cash history and peer comparisons.

AgomAb Therapeutics N.V. American Depositary Shares reported $220M in current cash as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AgomAb Therapeutics N.V. American Depositary Shares, and consider following AGMB for alerts when major investors trade the stock.

AgomAb Therapeutics N.V. American Depositary Shares is classified in the Healthcare sector. On current cash, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGMB with unrelated industries.